The activity of Enrofloxacina on bovine subclinical mastitis after systemic and intramammary administration was evaluated. As local treatment, 250mg of the product diluted in sterile distilled water to a final volume of 10ml, was infused into the teat during three days. The systemic treatment was performed with 5mg/kg of product administred intramuscularly, once a day, during the same period. The recovery was estimated three weeks after the treatment had finished through California Mastitis Test (CMT) and milk culture on blood agar and MacConkey agar. The drug was effective in 72.0% and 75.0% of 184 quarters with Staphylococcus aureus after intramammary and systemic treatments, respectively. Statystical analysis showed no significant differences (p<0.50) between both forms of treatment.
mastitis; enrofloxacin; therapy
